The Biden administration is officially moving to reclassify cannabis from a Schedule I drug to Schedule III. We talk about how it will impact research and the industry. Plus, what the future holds for cannabis equity in San Diego.
Bill could end holdup for studies on psychedelics, addiction treatment latimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from latimes.com Daily Mail and Mail on Sunday newspapers.
Bill could end holdup for California research on psychedelics and addiction treatment yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Addiction researchers want to kill powerful California panel sfchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sfchronicle.com Daily Mail and Mail on Sunday newspapers.
Across California, dozens of medical studies are in limbo thanks to a little-known government panel that monitors research on federally restricted drugs and addiction treatment.